9/10 May 2023
The EMA, together with the HMAs and the European Commission, is gradually implementing the priorities of its joint Accelerating Clinical Trials (ACT) initiative. Most recently, the European Commission published supplementary recommendations on "Decentralized Clinical Trials".
One of the ACT initiative's high-priority projects is a multi-stakeholder platform to support discussions in the clinical research landscape, facilitate the advancement of clinical trial methods and approaches, and help identify areas for progress and practical solutions to enable and drive change. A concept paper outlining the proposal for the creation of the platform has been published together with a press release inviting all stakeholders and the public to comment by 3 March 2023. Comments can be submitted directly online via a web form. The form also asks whether the respective stakeholder organisation is interested in participating in this platform.